1. Adelaide Research & Scholarship
  2. Schools and Disciplines
  3. School of Medicine
  4. Medicine
  5. Medicine publications
Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/9492
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorEvans, G.-
dc.contributor.authorCollett, M.-
dc.contributor.authorCame, N.-
dc.contributor.authorLloyd, J.-
dc.contributor.authorPowell, L.-
dc.contributor.authorStreet, A.-
dc.date.issued2002-
dc.identifier.citationHaemophilia, 2002; 8(5):635-638-
dc.identifier.issn1351-8216-
dc.identifier.issn1365-2516-
dc.identifier.urihttp://hdl.handle.net/2440/9492-
dc.description.abstract<jats:p><jats:bold>Summary. </jats:bold> MonoFIX‐VF, a monocomponent factor IX concentrate, has replaced the use of Prothrombinex‐HT as the treatment of choice for patients with factor IX deficiency in Australia. The haemostatic effect of MonoFIX‐VF, administered by continuous infusion, was assessed in four subjects being treated for 10 bleeding episodes including five surgical procedures. MonoFIX‐VF was found to be a safe and effective treatment for patients with haemophilia B.</jats:p>-
dc.language.isoen-
dc.publisherBlackwell Science Ltd-
dc.source.urihttp://dx.doi.org/10.1046/j.1365-2516.2002.00663.x-
dc.titleMonoFIX-VF, a new mono-component factor IX concentrate: a single-centre continuous-infusion study-
dc.typeJournal article-
dc.identifier.doi10.1046/j.1365-2516.2002.00663.x-
pubs.publication-statusPublished-
Appears in Collections:Aurora harvest 4
Medicine publications

Files in This Item:
There are no files associated with this item.
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.